Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Our Businesses
Explore more Johnson & Johnson sites:
Our Company

Developing Treatment for TB

Today's Top Reads Close

Insights on a new first-in-class drug indicated for multi-drug resistant tuberculosis from the development team at Janssen R&D.

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.